3rd Breast and Gynecological International Cancer Conference

Hlavní témata:

• Biology-Driven Selection of Adjuvant/Neoadjuvant Therapy of Primary Breast Cancer.
• State of the Art Anti-HER2 Therapy for Breast Cancer.
• Multidisciplinary Management of Metastatic Breast Cancer.
• The Concept of Personalised Medicine : is Breast Cancer the New Target ?
• State of the Art in the Adjuvant Chemotherapy in Breast Cancer: When to Use and When Not?
• Management of Triple Negative Breast Cancer Including PARP Inhibitors.
• Management of Women Who are at Increased Risk of Breast Cancer.
• Emerging Targeted Therapies in Breast Cancer .
• Primary Systemic Therapy in Breast Cancer: Novel Molecular Concepts.
• Sentinel Node Before and After Neoadjuvant Therapy.
• Decision Factors for Adjuvant Chemotherapy.
• Selection of Hormonal Treatment for Postmenopausal Breast Cancer Patients.
• What are Adequate Margins with Breast Conserving Therapy?
• Reconstruction Pros and Cons of Immediate Versus Delayed When Radiation is Necessary.
• Contact X-ray Applications in Breast and Gynecological Malignancies.
• HDR Interstitial Brachytherapy in Breast Cancer for Local Recurence After Initial Conservative Treatment.
• Do we Need to Reoperate the Positive SNB and Prognostic Value of the I+ and Micrometastatic SNB.
• Value of Hepatic Metastatectomy in Stage IV Breast Cancer .
• Partial Breast Radiation.
• Minimizing Local Recurrence: What is Proven and What is Not?
• HER2 Testing in Breast Cancer: Pitfalls.
• Recent Advances in HPV Research.
• New ASCCP Guidelines for the Management of Abnormal Pap Smear and Staging Advances in Gynecologic Cancers.
• Can we Blame Genes in the ERBB2 Amplicon for Trastuzumab Resistance?
• Cutting Edge of Breast Imaging with Mammography, Utrasound and Breast MRI.
• International Cooperation in the Field of Modern Oncology : Is It Only Useful for Long-Term Research or for the Practical Care of Egyptian Patients ?
• Cyperknife Value in Breast Cancer.